mutations and complicated kar yotype. It follows a linear evolution from the CLL clone through the recurrent acquisition of CDKN2ANot all sufferers with CLL involve therapy. Even with all latest innovations, the iwCLL continue to suggests watchful observation for people with asymptomatic condition.86 This suggestion relies on not less than two rand